seribantumab
elevation oncology
['crest', 'seribantumab']
#asco22 update on the crestone study by dr. of seribantumab, anti her3 igg2, in tumors with #nrg1 fusions. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him